OBJECTIVE: To determine the cost of rotavirus and all-cause diarrhoea in Vellore, India. METHODS: Parents of children <5 years of age accessing clinics, emergency rooms, or hospitals for acute diarrhoea completed a questionnaire detailing healthcare utilisation, medical and non-medical expenditures, and lost income. Faecal samples were screened for rotavirus and medical records were examined. Costs were estimated for inpatient and outpatient resource consumption, stratified by facility. RESULTS: Total societal costs of a hospitalised diarrhoeal episode were Rs 3278.50 (US$ 80.80) at a large referral hospital and Rs 1648.60 (US$ 40.60) at a smaller community hospital. Costs for rotavirus positive or negative gastroenteritis were similar. Median household expenditures per diarrhoeal episode at the referral and the community hospitals equalled 5.8% and 2.2% of the annual household income, respectively. CONCLUSIONS: Diarrhoeal disease in children constitutes a considerable economic burden. An appropriately priced and effective rotavirus vaccine may provide significant economic savings for the Indian household and healthcare system.
OBJECTIVE: To determine the cost of rotavirus and all-cause diarrhoea in Vellore, India. METHODS: Parents of children <5 years of age accessing clinics, emergency rooms, or hospitals for acute diarrhoea completed a questionnaire detailing healthcare utilisation, medical and non-medical expenditures, and lost income. Faecal samples were screened for rotavirus and medical records were examined. Costs were estimated for inpatient and outpatient resource consumption, stratified by facility. RESULTS: Total societal costs of a hospitalised diarrhoeal episode were Rs 3278.50 (US$ 80.80) at a large referral hospital and Rs 1648.60 (US$ 40.60) at a smaller community hospital. Costs for rotavirus positive or negative gastroenteritis were similar. Median household expenditures per diarrhoeal episode at the referral and the community hospitals equalled 5.8% and 2.2% of the annual household income, respectively. CONCLUSIONS:Diarrhoeal disease in children constitutes a considerable economic burden. An appropriately priced and effective rotavirus vaccine may provide significant economic savings for the Indian household and healthcare system.
Authors: Guillermo M Ruiz-Palacios; Irene Pérez-Schael; F Raúl Velázquez; Hector Abate; Thomas Breuer; SueAnn Costa Clemens; Brigitte Cheuvart; Felix Espinoza; Paul Gillard; Bruce L Innis; Yolanda Cervantes; Alexandre C Linhares; Pío López; Mercedes Macías-Parra; Eduardo Ortega-Barría; Vesta Richardson; Doris Maribel Rivera-Medina; Luis Rivera; Belén Salinas; Noris Pavía-Ruz; Jorge Salmerón; Ricardo Rüttimann; Juan Carlos Tinoco; Pilar Rubio; Ernesto Nuñez; M Lourdes Guerrero; Juan Pablo Yarzábal; Silvia Damaso; Nadia Tornieporth; Xavier Sáez-Llorens; Rodrigo F Vergara; Timo Vesikari; Alain Bouckenooghe; Ralf Clemens; Béatrice De Vos; Miguel O'Ryan Journal: N Engl J Med Date: 2006-01-05 Impact factor: 91.245
Authors: Timo Vesikari; David O Matson; Penelope Dennehy; Pierre Van Damme; Mathuram Santosham; Zoe Rodriguez; Michael J Dallas; Joseph F Heyse; Michelle G Goveia; Steven B Black; Henry R Shinefield; Celia D C Christie; Samuli Ylitalo; Robbin F Itzler; Michele L Coia; Matthew T Onorato; Ben A Adeyi; Gary S Marshall; Leif Gothefors; Dirk Campens; Aino Karvonen; James P Watt; Katherine L O'Brien; Mark J DiNubile; H Fred Clark; John W Boslego; Paul A Offit; Penny M Heaton Journal: N Engl J Med Date: 2006-01-05 Impact factor: 91.245
Authors: E Anthony S Nelson; John S Tam; Ly-Mee Yu; Ying-Chu Ng; Joseph S Bresee; Kin-Hung Poon; Chi-Hang Ng; Kin-Sing Ip; T Christopher Mast; Paul K-S Chan; Umesh D Parashar; Tai-Fai Fok; Roger I Glass Journal: J Infect Dis Date: 2005-09-01 Impact factor: 5.226
Authors: Laura Jean Podewils; Lynn Antil; Erik Hummelman; Joseph Bresee; Umesh D Parashar; Richard Rheingans Journal: J Infect Dis Date: 2005-09-01 Impact factor: 5.226
Authors: Thea K Fischer; Dang Duc Anh; Lynn Antil; N D L Cat; Paul E Kilgore; Vu D Thiem; Rick Rheingans; Le H Tho; Roger I Glass; Joseph S Bresee Journal: J Infect Dis Date: 2005-10-14 Impact factor: 5.226
Authors: Carlo Giaquinto; Pierre Van Damme; Frédéric Huet; Leif Gothefors; Marie Van der Wielen Journal: J Infect Dis Date: 2007-05-01 Impact factor: 5.226
Authors: Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass Journal: Emerg Infect Dis Date: 2003-05 Impact factor: 6.883
Authors: Emily R Smith; Emily E Rowlinson; Volga Iniguez; Kizee A Etienne; Rosario Rivera; Nataniel Mamani; Rick Rheingans; Maritza Patzi; Percy Halkyer; Juan S Leon Journal: Vaccine Date: 2011-09-02 Impact factor: 3.641
Authors: Johnie Rose; Laura Homa; Sharon B Meropol; Sara M Debanne; Roger Bielefeld; Claudia Hoyen; Mendel E Singer Journal: PLoS One Date: 2017-11-03 Impact factor: 3.240
Authors: T V Sowmyanarayanan; Tushar Patel; Rajiv Sarkar; Shobha Broor; Shobha D Chitambar; Triveni Krishnan; Rashmi Arora; Gagandeep Kang Journal: Indian J Med Res Date: 2012-07 Impact factor: 2.375
Authors: Rachel M Burke; Paulina A Rebolledo; Sally R Embrey; Laura Danielle Wagner; Carter L Cowden; Fiona M Kelly; Emily R Smith; Volga Iñiguez; Juan S Leon Journal: BMC Public Health Date: 2013-08-02 Impact factor: 3.295
Authors: Rachel M Burke; Emily R Smith; Rebecca Moritz Dahl; Paulina A Rebolledo; Maria del Carmen Calderón; Beatriz Cañipa; Edgar Chavez; Rolando Pinto; Luis Tamayo; Carlos Terán; Angel Veizaga; Remy Zumaran; Volga Iñiguez; Juan S Leon Journal: BMC Public Health Date: 2014-06-24 Impact factor: 3.295